Please use this identifier to cite or link to this item:
https://doi.org/10.1002/ejhf.1660
Title: | Mid-regional pro-adrenomedullin outperforms N-terminal pro-B-type natriuretic peptide for the diagnosis of acute heart failure in the presence of atrial fibrillation | Authors: | Kuan, Win Sen Ibrahim, Irwani Chan, S.P. LI ZISHENG Liew, O.W. Frampton, Chris Troughton, Richard Pemberton, Chris J JENNY CHONG PEK CHING TAN LI LING LIN WEIQIN Ooi, S.B.S. Richards, A.M. |
Keywords: | Science & Technology Life Sciences & Biomedicine Cardiac & Cardiovascular Systems Cardiovascular System & Cardiology MR-proADM NT-proBNP Acute heart failure Atrial fibrillation BIOMARKERS EPIDEMIOLOGY PERFORMANCE MANAGEMENT PROGNOSIS STATEMENT BACH |
Issue Date: | 6-Dec-2019 | Publisher: | WILEY | Citation: | Kuan, Win Sen, Ibrahim, Irwani, Chan, S.P., LI ZISHENG, Liew, O.W., Frampton, Chris, Troughton, Richard, Pemberton, Chris J, JENNY CHONG PEK CHING, TAN LI LING, LIN WEIQIN, Ooi, S.B.S., Richards, A.M. (2019-12-06). Mid-regional pro-adrenomedullin outperforms N-terminal pro-B-type natriuretic peptide for the diagnosis of acute heart failure in the presence of atrial fibrillation. EUROPEAN JOURNAL OF HEART FAILURE 22 (4) : 692-700. ScholarBank@NUS Repository. https://doi.org/10.1002/ejhf.1660 | Abstract: | Aims: The performance of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in diagnosing acute decompensated heart failure (ADHF) among patients presenting with breathlessness is markedly impaired in the presence of atrial fibrillation (AF). We evaluated the diagnostic performance of mid-regional pro-adrenomedullin (MR-proADM) and cardiac troponin T as possible alternative markers for discrimination of ADHF in this setting. Methods and results: Breathless patients (n = 1107) were prospectively and contemporaneously recruited in emergency departments in Singapore and New Zealand. The diagnoses of ADHF and presence of AF were adjudicated by two clinician specialists, blinded to MR-proADM, NT-proBNP and high-sensitivity cardiac troponin T (hs-cTnT) results. MR-proADM exhibited strong discrimination of ADHF with little change in performance irrespective of the presence of AF (area under the curve 0.83 in non-AF vs. 0.76 in AF) compared to NT-proBNP (0.91 vs. 0.71) and hs-cTnT (0.83 vs. 0.62), respectively. The accuracy of MR-proADM (73.3%) for diagnosing ADHF among patients with AF was superior to both NT-proBNP (61.6%) and hs-cTnT (64.6%). The superior performance of MR-proADM remained apparent when data from Singapore and New Zealand were analysed separately. Conclusion: In the presence of AF, MR-proADM showed greater discrimination and accuracy, and less impairment in performance compared to that in non-AF cases, for the diagnosis of ADHF, compared to the guideline-endorsed NT-proBNP. | Source Title: | EUROPEAN JOURNAL OF HEART FAILURE | URI: | https://scholarbank.nus.edu.sg/handle/10635/201971 | ISBN: | 1879-0844 | ISSN: | 1388-9842 | DOI: | 10.1002/ejhf.1660 |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
2019 MRproADM AF - EJHF.pdf | Accepted version | 254.16 kB | Adobe PDF | CLOSED | Published |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.